Jan Van Droogenbroeck, Jan

dr. Jan Van Droogenbroeck

Hematologie

Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.

In Acta Clinica Belgica 2011, in press
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

25th General Meeting of the Belgian Hematological Society, Oostende: lid organizing and scientific board, chairman ‘state of the art lectures’, business meeting: voorstelling financiële status.

Oostende, Belgium
29.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Belgian Hematological Society 29 en 30.01.10, te Oostende. – Is there an increased incidence of plasmablastic transformation in multiple myeloma after treatment with Imids and bortezomib?

Oostende, Belgium
29.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Posterabstract Belgian Hematological Society 29 en 30.01.10, te Oostende. Histiocytic sarcoma after acute precursor B lymphoblastic lymphoma: Case report.

Oostende, Belgium
29.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Posterabstract Belgian Hematological Society 29 en 30.01.10, te Oostende. Mixed phenotype acute leukaemia with MLL/AF4 rearrangement: A case report with sudden lineage switch.

Oostende, Belgium
29.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Results of Haploidentical Stem Cell Transplantation after a Conditioning Regimen without Total Body Irradiation in Elderly Patients with Advanced Myeloid and Lymphoid Malignancies.

Blood 2007;110: 3074
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/

Recommendations for the management of the haematological and onco-haematological aspects of Gaucher diseae.

British Journal of Haematology 2007;138:673-5
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/